Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and internal validation of a prognostic nomogram for overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib (PAZ)
    Meeting Abstract

    Kattan, M. W.; Chakrabarti, D.; Bhatt, K.; Mehmud, F.; Sternberg, C. N.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study
    Meeting Abstract

    Miller, K.; Scher, H. I.; Fizazi, K.; Basch, E. M.; Sternberg, C. N.; Hirmand, M.; Cella, D.; Ivanescu, C.; Phung, D.; Spalding, J. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3
    Meeting Abstract

    Milowsky, M. I.; Dittrich, C.; Martinez, I. D.; Jagdev, S.; Millard, F. E.; Sweeney, C.; Bajorin, D. F.; Cerbone, L.; Dunn, R. M.; Sen, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase Ib clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Molina, A. M.; Hutson, T. E.; Larkin, J. M. G.; Gold, A.; Andresen, C.; Wood, K.; Motzer, R. J.; Michaelson, M. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Efficacy and safety data from patients with advanced renal cell cancer treated with tivozanib hydrochloride after progression on sorafenib
    Meeting Abstract

    Motzer, R. J.; Nosov, D.; Tomczak, P.; Berkenblit, A.; Esteves, B.; Strahs, A. L.; Hutson, T. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC)
    Meeting Abstract

    Guancial, E. A.; Werner, L.; Bellmunt, J.; Nikitas, N.; Stack, E. C.; Lis, R.; Signoretti, S.; Loda, M.; Regan, M. M.; Park, R. S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of PFS and safety for Asian compared to North American and European populations in the phase III trial of pazopanib versus sunitinib in patients with treatment-naive RCC (COMPARZ)
    Meeting Abstract

    Guo, J.; Jin, J.; Huang, Y.; Wang, J. W.; Lim, H. Y.; Uemura, H.; Rha, S. Y.; Wu, H. C.; Crescenzo, R.; Deen, K. C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • MicroRNA as novel blood-based biomarkers in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mikkilineni, N.; Fiegoli, B.; Blass, S.; Grigoryev, Y.; Viale, A.; Socci, N. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Global metabolic profiling of clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Lee, C. H.; Cross, J. R.; Li, Z.; Chen, Y.; Neri, B.; Reuter, V. E.; Motzer, R. J.; Russo, P.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save